Your browser doesn't support javascript.
loading
Quantitative analysis of prion disease using an AI-powered digital pathology framework.
Salvi, Massimo; Molinari, Filippo; Ciccarelli, Mario; Testi, Roberto; Taraglio, Stefano; Imperiale, Daniele.
Afiliação
  • Salvi M; Biolab, PoliTo(BIO)Med Lab, Department of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129, Turin, Italy. massimo.salvi@polito.it.
  • Molinari F; Biolab, PoliTo(BIO)Med Lab, Department of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129, Turin, Italy.
  • Ciccarelli M; Biolab, PoliTo(BIO)Med Lab, Department of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129, Turin, Italy.
  • Testi R; SC Medicina Legale, ASL Città di Torino, Turin, Italy.
  • Taraglio S; SC Anatomia Patologica, ASL Città di Torino, Turin, Italy.
  • Imperiale D; SC Neurologia Ospedale Maria Vittoria & Centro Diagnosi Osservazione Malattie Prioniche, ASL Città di Torino, Turin, Italy.
Sci Rep ; 13(1): 17759, 2023 10 18.
Article em En | MEDLINE | ID: mdl-37853094
ABSTRACT
Prion disease is a fatal neurodegenerative disorder characterized by accumulation of an abnormal prion protein (PrPSc) in the central nervous system. To identify PrPSc aggregates for diagnostic purposes, pathologists use immunohistochemical staining of prion protein antibodies on tissue samples. With digital pathology, artificial intelligence can now analyze stained slides. In this study, we developed an automated pipeline for the identification of PrPSc aggregates in tissue samples from the cerebellar and occipital cortex. To the best of our knowledge, this is the first framework to evaluate PrPSc deposition in digital images. We used two strategies a deep learning segmentation approach using a vision transformer, and a machine learning classification approach with traditional classifiers. Our method was developed and tested on 64 whole slide images from 41 patients definitively diagnosed with prion disease. The results of our study demonstrated that our proposed framework can accurately classify WSIs from a blind test set. Moreover, it can quantify PrPSc distribution and localization throughout the brain. This could potentially be extended to evaluate protein expression in other neurodegenerative diseases like Alzheimer's and Parkinson's. Overall, our pipeline highlights the potential of AI-assisted pathology to provide valuable insights, leading to improved diagnostic accuracy and efficiency.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Priônicas / Proteínas Priônicas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Priônicas / Proteínas Priônicas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article